20.32
price up icon1.88%   0.375
after-market 시간 외 거래: 20.32
loading

Enliven Therapeutics Inc (ELVN) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
17.84%
31.69
26.90 27.07 24.60 25.99
Operating Income/Loss
17.84%
-31.69
-26.90 -27.07 -24.60 -25.99
Nonoperating Income/Loss
15.26%
3.149
3.716 3.912 4.653 3.249
Income/Loss From Continuing Operations Before Tax
23.14%
-28.54
-23.18 -23.16 -19.95 -22.74
Income/Loss From Continuing Operations After Tax
23.14%
-28.54
-23.18 -23.16 -19.95 -22.74
Net Income/Loss
23.14%
-28.54
-23.18 -23.16 -19.95 -22.74
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,251%
50.05
0.9354 48.27 48.08 42.05
Diluted Average Shares
5,251%
50.05
0.9354 48.27 48.08 42.05
Basic Earnings Per Share
23.91%
-0.57
-0.46 -0.48 -0.41 -0.54
Diluted Earnings Per Share
23.91%
-0.57
-0.46 -0.48 -0.41 -0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.54
price up icon 0.95%
$84.00
price down icon 0.90%
$26.98
price up icon 2.70%
$104.79
price down icon 0.27%
$132.17
price up icon 3.00%
biotechnology ONC
$308.91
price up icon 0.09%
자본화:     |  볼륨(24시간):